enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Sanofi

    Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...

  3. Chattem - Wikipedia

    en.wikipedia.org/wiki/Chattem

    The company is a subsidiary of the French multinational pharmaceutical company Sanofi. The company’s brands are sold nationally through mass merchandiser, drug and food retailers. In 2005, 70% of the firm's sales were made through its top ten customers, which include Wal-Mart , Walgreens , and Kroger.

  4. Sanofi Pasteur - Wikipedia

    en.wikipedia.org/wiki/Sanofi_Pasteur

    Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines. It is one of four global producers of the yellow fever vaccine. [2]

  5. Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings ... - AOL

    www.aol.com/sanofi-raises-2024-profit-outlook...

    On Thursday, Sanofi SA (NASDAQ:SNY) reported a second-quarter business operating income of 2.8 billion euros ($3.03 billion), up 3.2% year-over-year and 8.3% in constant currency. The company ...

  6. Genzyme - Wikipedia

    en.wikipedia.org/wiki/Genzyme

    Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts.From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi.

  7. Sanofi CEO believes company poised for growth from new drugs

    www.aol.com/news/sanofi-ceo-still-considering...

    NEW YORK (Reuters) -Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent ...

  8. AstraZeneca, Sanofi to supply 230,000 more RSV infant shots ...

    www.aol.com/news/drugmakers-push-230-000-more...

    According to a statement from one of the drug's makers - France's Sanofi - the additional supply means the companies will deliver 1.4 million doses of the drug in the U.S. this year, over 25% more

  9. Rhône-Poulenc - Wikipedia

    en.wikipedia.org/wiki/Rhône-Poulenc

    Rhône-Poulenc (French pronunciation: [ʁon pulɛ̃k]) was a French chemical and pharmaceutical company founded in 1928.In 1999, it merged with Hoechst AG to form Aventis.As of 2015, the pharmaceutical operations of Rhône-Poulenc are part of Sanofi and the chemicals divisions are part of Solvay group and Bayer Crop Science.